Teligent
TLGT
#10190
Rank
NZ$26.93 M
Marketcap
NZ$0.28
Share price
-13.85%
Change (1 day)
1,535.31%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Earnings for Teligent (TLGT)

Earnings in 2021 (TTM): -NZ$62.91 Million

According to Teligent's latest financial reports the company's current earnings are NZ$46.29 Million. In 2020 the company made an earning of -NZ$64.24 Million a decrease over its 2019 earnings that were of -NZ$13.42 Million.

Earnings history for Teligent from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$62.91 Million-2.08%
2020-NZ$64.24 Million378.89%
2019-NZ$13.42 Million-46.87%
2018-NZ$25.25 Million10.47%
2017-NZ$22.86 Million-637.49%
2016NZ$4.25 M-179.64%
2015-NZ$5.34 Million-181.72%
2014NZ$6.53 M-4806.02%
2013-NZ$0.14 Million-97.35%
2012-NZ$5.25 Million6.23%
2011-NZ$4.94 Million-18.59%
2010-NZ$6.07 Million-11.37%
2009-NZ$6.85 Million98.4%
2008-NZ$3.45 Million156.15%
2007-NZ$1.35 Million-59.36%
2006-NZ$3.32 Million17.92%
2005-NZ$2.81 Million37.7%
2004-NZ$2.05 Million25.51%
2003-NZ$1.63 Million-289.84%
2002NZ$0.85 M-1605.88%
2001-NZ$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.27 Billion 262.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.37 Million-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA